Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    AEON Biopharma Inc.

    NASDAQ: AEON · Real-Time Price · USD
    0.75
    -0.01 (-1.68%)
    At close: Jun 27, 2025, 3:58 PM
    0.74
    -0.78%
    After-hours: Jun 27, 2025, 05:40 PM EDT

    AEON Biopharma Statistics

    Share Statistics

    AEON Biopharma has 11.31M shares outstanding. The number of shares has increased by 861.53% in one year.

    Shares Outstanding

    n/a
    		 11.31M

    Shares Change (YoY)

    n/a
    		 861.53%

    Shares Change (QoQ)

    n/a
    		 841.12%

    Owned by Institutions (%)

    n/a
    		 99.99%

    Shares Floating

    n/a
    		 7.86M

    Failed to Deliver (FTD) Shares

    n/a
    		 n/a

    FTD / Avg. Volume

    n/a
    		 n/a

    Short Selling Information

    The latest short interest is 1.18M, so 10.42% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 1.18M

    Short % of Shares Out

    n/a
    		 10.42%

    Short % of Float

    n/a
    		 10.45%

    Short Ratio (days to cover)

    n/a
    		 1

    Valuation Ratios

    The PE ratio is 0.01 and the forward PE ratio is null. AEON Biopharma's PEG ratio is 0.

    PE Ratio

    n/a
    		 0.01

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 -0.01

    P/FCF Ratio

    n/a
    		 -0.01

    PEG Ratio

    n/a
    		 0
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for AEON Biopharma.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 0.11, with a Debt / Equity ratio of -0.45.

    Current Ratio

    n/a
    		 0.11

    Quick Ratio

    n/a
    		 0.11

    Debt / Equity

    n/a
    		 -0.45

    Debt / EBITDA

    n/a
    		 -0.47

    Debt / FCF

    n/a
    		 -0.64

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $8,401,000

    Employee Count

    n/a
    		 5

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by null% in the last 52 weeks. The beta is 0.57, so AEON Biopharma's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.57

    52-Week Price Change

    n/a
    		 n/a

    50-Day Moving Average

    n/a
    		 0.59

    200-Day Moving Average

    n/a
    		 25.35

    Relative Strength Index (RSI)

    n/a
    		 52.92

    Average Volume (20 Days)

    n/a
    		 n/a

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 72.98M

    Net Income

    n/a
    		 42.01M

    EBITDA

    n/a
    		 -27.73M

    EBIT

    n/a
    		 -27.82M

    Earnings Per Share (EPS)

    n/a
    		 5597.28
    Full Income Statement

    Balance Sheet

    The company has 13K in cash and 12.96M in debt, giving a net cash position of -12.94M.

    Cash & Cash Equivalents

    n/a
    		 13K

    Total Debt

    n/a
    		 12.96M

    Net Cash

    n/a
    		 -12.94M

    Retained Earnings

    n/a
    		 -431.6M

    Total Assets

    n/a
    		 13.8M

    Working Capital

    n/a
    		 3.68M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -20.29M and capital expenditures 0, giving a free cash flow of -20.29M.

    Operating Cash Flow

    n/a
    		 -20.29M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -20.29M

    FCF Per Share

    n/a
    		 -2703.8
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    AEON does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for AEON.

    Price Target

    n/a
    		 $360

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 1
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Feb 26, 2025. It was a backward split with a ratio of 1:72.

    Last Split Date

    n/a
    		 Feb 26, 2025

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:72

    Scores

    Altman Z-Score

    n/a
    		 -47.47

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist